Evidence map›Paper›PMID 27237376›Full record

ArticleStem cell reports2016

H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.

Akira Kunitomi, Shinsuke Yuasa, Fumihiro Sugiyama, Yuki Saito, Tomohisa Seki, Dai Kusumoto, Shin Kashimura, Makoto Takei, Shugo Tohyama, Hisayuki Hashimoto and 15 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Salivary Gland Bioengineering.Bioengineering (Basel, Switzerland) · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Various nuclear reprogramming systems using egg and oocyte materials.The Journal of reproduction and development · 2019
    Review
  18. Potential application of cell reprogramming techniques for cancer research.Cellular and molecular life sciences : CMLS · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 3 institutions in 2 countries.

Akira KunitomiDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Shinsuke YuasaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: yuasa@keio.jp.
Fumihiro SugiyamaLaboratory Animal Resource Center, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Yuki SaitoDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Tomohisa SekiDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Dai KusumotoDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Shin KashimuraDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Makoto TakeiDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Shugo TohyamaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Hisayuki HashimotoDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Toru EgashiraDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Yoko TanimotoLaboratory Animal Resource Center, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Saori MizunoLaboratory Animal Resource Center, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Shoma TanakaDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Hironobu OkunoDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Kazuki YamazawaDepartment of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan.
Hideo WatanabeDivision of Pulmonary, Critical Care and Sleep Medicine, Departments of Medicine and Genetics and Genomic Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Mayumi OdaSakaguchi Laboratory, Department of Systems Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
Ruri KanedaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Yumi MatsuzakiDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Toshihiro NagaiElectron Microscope Laboratory, Keio University School of Medicine, Tokyo 160-8582, Japan.
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Ken-Ichi YagamiLaboratory Animal Resource Center, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Mamoru TanakaDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Keiichi FukudaDepartment of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.
Keio University · JPUniversity of Tsukuba · JPIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embryonic stem cells (ESCs) are a hallmark of ideal pluripotent stem cells. Epigenetic reprogramming of induced pluripotent stem cells (iPSCs) has not been fully accomplished. iPSC generation is similar to somatic cell nuclear transfer (SCNT) in oocytes, and this procedure can be used to generate ESCs (SCNT-ESCs), which suggests the contribution of oocyte-specific constituents. Here, we show that the mammalian oocyte-specific linker histone H1foo has beneficial effects on iPSC generation. Induction of H1foo with Oct4, Sox2, and Klf4 significantly enhanced the efficiency of iPSC generation. H1foo promoted in vitro differentiation characteristics with low heterogeneity in iPSCs. H1foo enhanced the generation of germline-competent chimeric mice from iPSCs in a manner similar to that for ESCs. These findings indicate that H1foo contributes to the generation of higher-quality iPSCs.

Indexed as

Cellular ReprogrammingEpigenesis, GeneticAnimalsChimerismEmbryo, MammalianFemaleFibroblastsGene ExpressionHistonesInduced Pluripotent Stem CellsKruppel-Like Factor 4Kruppel-Like Transcription FactorsMiceMice, TransgenicOctamer Transcription Factor-3OocytesH1f8 protein, mouseHistonesKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsMyc protein, mouseOctamer Transcription Factor-3Pou5f1 protein, mouseProto-Oncogene Proteins c-mycSox2 protein, mouseSOXB1 Transcription Factors

Identifiers

PMID27237376
PMCPMC4912480
OpenAlexW2400877562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.